Diabetic retinopathy, vitreous hemorrhage with traction retinal detachment
Conditions
Interventions
Intravitreal injection group(non-Exposure group):Intravitreal injection of anti-VEGF agents
Subretinal injection group(Exposure group):Subretinal injection of anti-VEGF agents
Sponsors
Affiliated Eye Hospital of Nanchang University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with diabetic retinopathy complicated by vitreous hemorrhage and tractional retinal detachment who underwent vitrectomy and silicone oil injection, and still had diabetic macular edema (DME) after three consecutive and regular anti-VEGF treatments, with a central retinal thickness (CRT) of the macula >300 µm.
Exclusion criteria
Exclusion criteria: Patients with significant opacification of the ocular media, making it impossible to obtain preoperative optical coherence tomography (OCT) images, a history of pars plana vitrectomy (PPV) surgery, significant retinal pigment epithelium (RPE) atrophy, active or high-risk proliferative diabetic retinopathy, tractional retinal detachment, neovascular glaucoma, and those with monocular vision.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Central macular thickness; | — |
Countries
China
Contacts
Public ContactYou Zhipeng
Affiliated Eye Hospital of Nanchang University
Outcome results
None listed